NovoCure Ltd·4

Mar 3, 4:10 PM ET

Puri Michal Nath 4

Research Summary

AI-generated summary

Updated

NovoCure (NVCR) CHRO Michal Puri Sells 1,441 Shares

What Happened
Michal Puri, Chief Human Resources Officer of NovoCure Ltd (NVCR), sold 1,441 shares on February 27, 2026 in an open-market "sell-to-cover" transaction. The weighted average sale price was $13.66 per share, producing aggregate proceeds of approximately $19,690. This sale was executed to satisfy tax withholding obligations tied to the vesting of Restricted Stock Units and was mandated by the company’s award agreement—not a discretionary trade.

Key Details

  • Transaction date: 2026-02-27 (Filed: 2026-03-03; filing appears timely)
  • Trade details: 1,441 shares sold; weighted average price $13.66; total proceeds ≈ $19,690
  • Price range: executed in multiple trades at $13.45–$13.97 (weighted avg reported)
  • Reason/footnote: Sale required to cover tax withholding on RSU vesting (mandated by award agreement) — not an elective market-timing sale
  • Shares owned after transaction: Not disclosed in the information provided

Context
Sell-to-cover transactions are common when restricted shares or RSUs vest and the issuer’s plan requires withholding taxes be satisfied by selling a portion of the shares. Such mandated sales generally reflect tax mechanics rather than a manager’s view on the company’s stock.